Cutler Group LP Novavax Inc Put Options Transaction History

Cutler Group LP

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Jul 18, 2023	SELL	$6.67 - $9.52 $12,673 - $18,088	-1,900 Reduced 65.52%	1,000 $2,000
Q1 2023 May 01, 2023	SELL	$5.76 - $12.48 $158,400 - $343,200	-27,500 Reduced 90.46%	2,900 $12,000
Q4 2022 Feb 07, 2023	BUY	$8.86 - $25.04 $30,123 - $85,136	3,400 Added 12.59%	30,400 $51,000
Q3 2022 Oct 25, 2022	SELL	$18.2 - $76.12 $342,160 - $1.43 Million	-18,800 Reduced 41.05%	27,000 $1.44 Million
Q2 2022 Aug 04, 2022	SELL	$36.28 - $75.29 $1.75 Million - $3.64 Million	-48,300 Reduced 51.33%	45,800 $1.84 Million
Q1 2022 Apr 14, 2022	BUY	$69.73 - $142.9 $404,434 - $828,820	5,800 Added 6.57%	94,100 $2.33 Million
Q4 2021 Jan 18, 2022	BUY	$134.56 - $217.97 $9.11 Million - $14.8 Million	67,700 Added 328.64%	88,300 $2.07 Million
Q3 2021 Oct 26, 2021	BUY	$177.8 - $270.58 $106,680 - $162,348	600 Added 3.0%	20,600 $389,000
Q2 2021 Jul 19, 2021	BUY	$121.0 - $257.67 $1.98 Million - $4.23 Million	16,400 Added 455.56%	20,000 $491,000
Q1 2021 Apr 26, 2021	SELL	$112.98 - $319.93 $1.51 Million - $4.29 Million	-13,400 Reduced 78.82%	3,600 $94,000
Q4 2020 Jan 21, 2021	SELL	$78.74 - $139.5 $456,691 - $809,100	-5,800 Reduced 25.44%	17,000 $219,000
Q3 2020 Oct 27, 2020	SELL	$79.44 - $178.51 $985,056 - $2.21 Million	-12,400 Reduced 35.23%	22,800 $142,000
Q2 2020 Jul 22, 2020	BUY	$13.86 - $83.61 $451,836 - $2.73 Million	32,600 Added 1253.85%	35,200 $264,000
Q1 2020 May 07, 2020	BUY	$3.93 - $16.0 $10,218 - $41,600	2,600 New	2,600 $2,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.